Sun et al. reported that changes in CAPZ expression could be used as a diagnostic marker for malignant melanoma [26], and Yu et al. observed that CAPZA1 expression was reduced in stage IV neuroblastoma [27]. The gene discussed is CAPZA1; the disease is neuroblastoma.